A review of nebulized drug delivery in COPD
DP Tashkin - … Journal of Chronic Obstructive Pulmonary Disease, 2016 - Taylor & Francis
Current guidelines recommend inhaled pharmacologic therapy as the preferred route of
administration for treating COPD. Bronchodilators (β2-agonists and antimuscarinics) are the …
administration for treating COPD. Bronchodilators (β2-agonists and antimuscarinics) are the …
[HTML][HTML] A review of nebulized drug delivery in COPD
DP Tashkin - … Journal of Chronic Obstructive Pulmonary Disease, 2016 - ncbi.nlm.nih.gov
Current guidelines recommend inhaled pharmacologic therapy as the preferred route of
administration for treating COPD. Bronchodilators (β 2-agonists and antimuscarinics) are the …
administration for treating COPD. Bronchodilators (β 2-agonists and antimuscarinics) are the …
[PDF][PDF] A review of nebulized drug delivery in COPD
DP Tashkin - International Journal of COPD, 2016 - scienceopen.com
Current guidelines recommend inhaled pharmacologic therapy as the preferred route of
administration for treating COPD. Bronchodilators (β2-agonists and antimuscarinics) are the …
administration for treating COPD. Bronchodilators (β2-agonists and antimuscarinics) are the …
A review of nebulized drug delivery in COPD
DP Tashkin - … Journal of Chronic Obstructive Pulmonary Disease, 2016 - dovepress.com
Current guidelines recommend inhaled pharmacologic therapy as the preferred route of
administration for treating COPD. Bronchodilators (β 2-agonists and antimuscarinics) are the …
administration for treating COPD. Bronchodilators (β 2-agonists and antimuscarinics) are the …
A review of nebulized drug delivery in COPD
DP Tashkin - International Journal of Chronic Obstructive Pulmonary …, 2016 - go.gale.com
Current guidelines recommend inhaled pharmacologic therapy as the preferred route of
administration for treating COPD. Bronchodilators ([[beta]. sub. 2]-agonists and …
administration for treating COPD. Bronchodilators ([[beta]. sub. 2]-agonists and …
[PDF][PDF] A review of nebulized drug delivery in COPD
DP Tashkin - International Journal of COPD, 2016 - begol.ir
Current guidelines recommend inhaled pharmacologic therapy as the preferred route of
administration for treating COPD. Bronchodilators (β2-agonists and antimuscarinics) are the …
administration for treating COPD. Bronchodilators (β2-agonists and antimuscarinics) are the …
A review of nebulized drug delivery in COPD.
DP Tashkin - … Journal of Chronic Obstructive Pulmonary Disease, 2016 - europepmc.org
Current guidelines recommend inhaled pharmacologic therapy as the preferred route of
administration for treating COPD. Bronchodilators (β 2-agonists and antimuscarinics) are the …
administration for treating COPD. Bronchodilators (β 2-agonists and antimuscarinics) are the …
A review of nebulized drug delivery in COPD
DP Tashkin - International journal of chronic obstructive …, 2016 - pubmed.ncbi.nlm.nih.gov
Current guidelines recommend inhaled pharmacologic therapy as the preferred route of
administration for treating COPD. Bronchodilators (β 2-agonists and antimuscarinics) are the …
administration for treating COPD. Bronchodilators (β 2-agonists and antimuscarinics) are the …
[PDF][PDF] A review of nebulized drug delivery in COPD
DP Tashkin - International Journal of COPD, 2016 - pdfs.semanticscholar.org
Current guidelines recommend inhaled pharmacologic therapy as the preferred route of
administration for treating COPD. Bronchodilators (β2-agonists and antimuscarinics) are the …
administration for treating COPD. Bronchodilators (β2-agonists and antimuscarinics) are the …
[引用][C] A review of nebulized drug delivery in COPD
D Tashkin - International Journal of Chronic Obstructive Pulmonary …, 2016 - cir.nii.ac.jp